Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

被引:11
|
作者
Moore, Sara [1 ,2 ]
Leung, Bonnie [2 ]
Wu, Jonn [1 ,3 ]
Ho, Cheryl [1 ,2 ]
机构
[1] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada
[2] BC Canc, Dept Med Oncol, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada
[3] BC Canc, Dept Radiat Oncol, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada
关键词
Non-small cell lung cancer; Stage II; Inoperable; Real-world; Outcomes; VINORELBINE PLUS CISPLATIN; ADJUVANT CHEMOTHERAPY; POOLED ANALYSIS; PATTERNS; MANAGEMENT; OUTCOMES; NSCLC;
D O I
10.1186/s13014-020-1466-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives Curative intent therapy of stage II NSCLC may include surgical resection or definitive radiotherapy. Primary management with surgery or radiotherapy may be influenced by patient and disease characteristics. We sought to perform a comparison of patients receiving surgery or radical radiation therapy as their curative treatment, and explore the impact of known prognostic factors on outcome. Materials and methods A retrospective review was completed of all patients with stage II NSCLC referred to the BC Cancer Agency from 2005 to 2012. Cases were filtered to identify those receiving curative intent therapy including surgery or radiotherapy. Information was collected on known prognostic and predictive factors. The primary outcome measure was overall survival. We compared survival among patients receiving curative intent radiotherapy versus surgical intervention. Results A total of 535 patients were referred. Of these, 245 (46%) received curative intent surgery, 132 (25%) curative intent radiotherapy, and 158 (30%) did not receive curative therapy. There were significant differences between cohorts with respect to median age, histology, ECOG PS, smoking status, and weight loss. Median OS was significantly different between cohorts: 61.4 m surgery, 26.5 m curative RT, and 13.1 m non-curative therapy. In a case-matched analysis, median OS remained superior for surgery at 101.6 m vs 28.1 m for curative RT. In a multivariate analysis, ECOG PS, weight loss, and treatment cohort all influenced survival. Among patients receiving curative intent radiotherapy, the use of concurrent chemotherapy and RT dose > = 60Gy were associated with improved outcomes. Conclusions Among patients with stage II NSCLC, many are unable to undergo standard of care surgical resection. Radiotherapy provides an inferior yet still curative option in the management of inoperable patients. Further work is needed to optimize outcomes in this population.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients
    Sara Moore
    Bonnie Leung
    Jonn Wu
    Cheryl Ho
    Radiation Oncology, 15
  • [2] Radiotherapy for medically inoperable non-small cell lung cancer at clinical stage I and II
    Yamada, K
    Soejima, T
    Ota, Y
    Sasaki, R
    Yoden, E
    Kanaoka, N
    Maruta, T
    Sugimura, K
    TUMORI, 2003, 89 (01) : 75 - 79
  • [3] Hypofractionated radiotherapy for medically inoperable stage I non-small cell lung cancer
    Jiang, Wei
    Wang, Jian-Yang
    Wang, Jing-Bo
    Liang, Jun
    Hui, Zhou-Guang
    Wang, Xiao-Zhen
    Zhou, Zong-Mei
    Wang, Lu-Hua
    THORACIC CANCER, 2016, 7 (03) : 296 - 303
  • [4] Disparities in Treatment of Patients with Inoperable Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis
    Koshy, Matthew
    Malik, Renuka
    Spiotto, Mike
    Mahmood, Usama
    Weichselbaum, Ralph
    Sher, David
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (02) : 264 - 271
  • [5] Early stage medically inoperable non-small cell lung cancer
    Jeffrey A. Bogart
    Ernest Scalzetti
    Elisabeth Dexter
    Current Treatment Options in Oncology, 2003, 4 (1) : 81 - 88
  • [6] Radiotherapy alone in elderly patients with medically inoperable stage IIIA and IIIB non-small cell lung cancer
    Tombolini, V
    Bonanni, A
    Donato, V
    Raffetto, N
    Santarelli, M
    Valeriani, M
    Enrici, RM
    ANTICANCER RESEARCH, 2000, 20 (6C) : 4829 - 4833
  • [7] Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer
    Price, Allan
    Yellowlees, Ann
    Keerie, Catriona
    Russell, Susan
    Faivre-Finn, Corinne
    Gilligan, David
    Snee, Michael
    Skailes, Geraldine
    Hatton, Matthew
    Erridge, Sara
    Mohammed, Nazia
    LUNG CANCER, 2012, 77 (03) : 532 - 536
  • [8] Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer
    Falkson, C. B.
    Vella, E. T.
    Yu, E.
    El-Mallah, M.
    Mackenzie, R.
    Ellis, P. M.
    Ung, Y. C.
    CURRENT ONCOLOGY, 2017, 24 (01) : E44 - E49
  • [9] Radical radiotherapy for medically inoperable early stage I/II non small cell lung cancer
    Korda, N. Jovanovic
    Vucicevic, S.
    Gligorijevic, G.
    Lukac, B.
    LUNG CANCER, 2006, 52 : S34 - S34
  • [10] Stereotactic Body Radiotherapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
    Hu, Chen
    JAMA ONCOLOGY, 2024,